Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Jul 23;332(4):310-317.
doi: 10.1001/jama.2024.8684.

A More Selective vs a Standard Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol

Macie L Champion  1 , Christina T Blanchard  1 , Michelle Y Lu  2 , Ashley E Shea  1 , Anna I Lively  3 , J Morgan Jenkins  3 , Samantha E Howell  1 , Grace M Lee  1 , Brian M Casey  4 , Ashley N Battarbee  1 , Akila Subramaniam  1
Affiliations
Observational Study

A More Selective vs a Standard Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol

Macie L Champion et al. JAMA. .

Abstract

Importance: In 2016, our institution adopted a pregnancy-related venous thromboembolism (VTE) prophylaxis protocol based on American College of Obstetricians and Gynecologists guidelines that recommended postpartum heparin-based chemoprophylaxis (enoxaparin) based on a risk-stratified algorithm. In response to increased wound hematomas without significant reduction in VTE using this protocol, a more selective risk-stratified approach was adopted in 2021.

Objective: To evaluate outcomes of the more selective risk-stratified approach to heparin-based obstetric thromboprophylaxis (enoxaparin) protocol.

Design, setting, and participants: Retrospective observational study of 17 489 patients who delivered at a single tertiary care center in the southeast US between January 1, 2016, and December 31, 2018 (original protocol), and between December 1, 2021, and May 31, 2023 (more selective protocol). Patients receiving outpatient anticoagulation for active VTE or high VTE risk during pregnancy were excluded.

Exposure: Standard risk-stratified and more selective postpartum VTE chemoprophylaxis protocols.

Main outcomes and measures: The primary outcome was clinical diagnosis of wound hematoma up to 6 weeks pos tpartum. The secondary outcome was new diagnosis of VTE up to 6 weeks post partum. We compared baseline characteristics and outcomes between groups and estimated adjusted odds ratios with 95% CIs of primary and secondary outcomes using the original protocol group as reference.

Results: Of 17 489 patients included in the analysis, 12 430 (71%) were in the original protocol group and 5029 (29%) were in the more selective group. Rates of chemoprophylaxis decreased from 16% (original protocol) to 8% (more selective protocol). Patients in the more selective group were more likely to be older, be married, and have obesity or other comorbidities (hypertension, diabetes, cardiac disease). Compared with the original protocol, the more selective protocol was associated with a decrease in any wound hematoma (0.7% vs 0.3%; adjusted odds ratio [aOR], 0.38; 95% CI, 0.21-0.67), specifically due to a lower rate of superficial wound hematomas (0.6% vs 0.3%; aOR, 0.43; 95% CI, 0.24-0.75). There was no significant increase in VTE or individual types of VTE (0.1% vs 0.1%; aOR, 0.40; 95% CI, 0.12-1.36).

Conclusions and relevance: A more selective risk-stratified approach to an enoxaparin thromboprophylaxis protocol for VTE was associated with decreased rates of wound hematomas without increased rates of postpartum VTE.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Subramaniam reported advisory board membership for Novocuff and receipt of grants from the National Institutes of Health outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Study Disposition of Patients
See this image and copyright information in PMC

References

    1. Rodger M. Pregnancy and venous thromboembolism: ‘TIPPS’ for risk stratification. Hematology Am Soc Hematol Educ Program. 2014;2014(1):387-392. doi:10.1182/asheducation-2014.1.387 - DOI - PubMed
    1. Friedman AM, D’Alton M. Society for Maternal-Fetal Medicine Consult Series #51: thromboembolism prophylaxis for cesarean delivery. Am J Obstet Gynecol. 2021;224(2):243-244. doi:10.1016/j.ajog.2020.09.033 - DOI - PubMed
    1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics . ACOG Practice Bulletin No. 196: thromboembolism in pregnancy. Obstet Gynecol. 2018;132(1):e1-e17. doi:10.1097/AOG.0000000000002706 - DOI - PubMed
    1. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ III. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697-706. doi:10.7326/0003-4819-143-10-200511150-00006 - DOI - PubMed
    1. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632-637. doi:10.1111/j.1538-7836.2008.02921.x - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources